The Justice Department has charged a Texas doctor in an $89 million health care fraud scheme, accusing him of billing ...
The FDA told wearable maker Whoop last week that it would not take further enforcement action over the company's blood ...
Regenxbio plans to submit its Duchenne gene therapy for FDA approval, just a month after it said that regulators wanted to ...
EchoNext, a new AI tool cleared by the FDA, will let doctors use an EKG to easily screen patients for structural heart ...
With the right structure, Americans will roll up their sleeves, do the science, and trust the result,” Manoush Zomorodi ...
Relatively speaking, the least controversial application of human embryo genome editing is to use it to try to prevent ...
The federal government can't block benefits from the nation's largest food aid program from being used to buy candy, soda, ...
Digital health startup Cadence has raised $100 million at a $1.23 billion valuation to expand its chronic disease management ...
Back in 2020, STAT named promising young researcher Pierre Elias to our annual list of Wunderkinds. Today, I published a ...
Pfizer disclosed that an experimental lung cancer drug it hoped could replace a widely used chemotherapy fell short in a clinical trial, STAT writes. Expectations had been high that the drug, ...
Ed’s stories explore prescription drug pricing, affordability and access, as well issues surrounding patents, litigation, and ...
Allison covers what hot startups are getting up to, and who’s financing them. She is also co-host of the weekly biotech podcast, “The Readout Loud.” You can reach Allison on Signal at AllisonDeAngelis ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results